New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 1, 2013
07:08 EDTCVS, RAD, WAGDrugstore chains see opportunity in heal-care services, WSJ reports
Drugstore chains (CVS, WAG, RAD) are branching out into health-care services, as a way to counter a slowdown in prescription drug sales and evolve beyond just dispensing pills. They see big opportunities as millions of uninsured Americans pick up health coverage next year. The upside is in making sure current patients stay on their medications or providing alternative venues for medical treatment, even if it is done virtually, reports the Wall Street Journal.Reference Link
News For CVS;WAG;RAD From The Last 14 Days
Check below for free stories on CVS;WAG;RAD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
May 22, 2013
09:21 EDTRADRite Aid management to meet with Guggenheim
Subscribe for More Information
May 20, 2013
16:02 EDTRADOptions Update; May 20, 2013
Subscribe for More Information
15:52 EDTWAGWalgreen downgraded to Market Perform from Outperform at Barrington
Subscribe for More Information
15:23 EDTRADRite Aid July and October volatility low as shares at 62-month high
Subscribe for More Information
May 17, 2013
12:33 EDTWAGAmerisourceBergen receives approval of Walgreens, Alliance Boots investment
AmerisourceBergen (ABC) announced that the parties have received regulatory approval of the previously disclosed agreement for Walgreen (WAG) and Alliance Boots GmbH to purchase an equity stake in the company. AmerisourceBergen continues to expect the new agreements to contribute an incremental $25B in revenues and approximately 20c in earnings per share in FY14, excluding the amortization of certain expenses related to the transaction and the warrants issued, certain non-recurring costs and a potential LIFO charge, and net of certain start up expenses. In addition, the company reiterated its expectations for financial performance for fiscal year 2013, which includes expected revenue growth in the 11%-13% range, and diluted earnings per share from continuing operations in the lower half of the range of $3.04 to $3.14, excluding certain expenses related to the relationship with Walgreens and Alliance Boots and the warrants issued, and the expected LIFO charge from onboarding of additional branded inventory.
May 15, 2013
17:30 EDTCVSRelational Investors gives quarterly update on stakes
Subscribe for More Information
May 13, 2013
09:56 EDTCVSCVS Caremark has a conference call hosted by JPMorgan
JPMorgan Analyst Gill will host a conference call with CEO Larry Merlo on May 16 at 11 am.
08:32 EDTCVS, WAGWalgreens extends CVS Caremark network provider agreement
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.